The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Regulatory T cells (Tregs) that express the transcription factor Foxp3 are critical for regulating intestinal inflammation. Candidate microbe approaches have identified bacterial species and strain-specific molecules that can affect intestinal immune responses, including species that modulate Treg responses. Because neither all humans nor mice harbor the same bacterial strains, we posited that more prevalent factors exist that regulate the number and function of colonic Tregs. We determined that short-chain fatty acids, gut microbiota-derived bacterial fermentation products, regulate the size and function of the colonic Treg pool and protect against colitis in a Ffar2-dependent manner in mice. Our study reveals that a class of abundant microbial metabolites underlies adaptive immune microbiota coadaptation and promotes colonic homeostasis and health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“acetate and propionate, but not butyrate, stimulate the expansion of pre-existing colonic Tregs (cTregs)”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Smith et al., 2013
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“and on DCs, conferring a higher capacity to drive naïve T cell differentiation into Tregs [38-40].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [40]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“SCFAs promote the development of naive CD4+ T cells into regulatory T cells (31, 32), induce “tolerogenic” dendritic cells in the intestinal mucosa (33), and limit autoimmity (34, 35).”
From Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. (2018) · cites this paper as [31]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFAs serve as ligands for GPR41 and GPR43 on intestinal Tregs and epithelial cells, leading to activation mitogen-activated protein kinase signaling and secretion of chemokines and cytokines11,40.”
From Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer (2021) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFAs have context-dependent functions: they can promote the expansion of Treg cells and also improve effector T cell functions133–136.”
From Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy (2023) · cites this paper as [134]
Experimental — accuracy not yet measured
22 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 1×
“While the gut microbiota composition is divergent across individuals, functional gene profiles are quite similar (24, 25), and alterations to common gut microbial metabolic pathways may affect production of symbiotic factors, such as SCFA, which regulate intestinal adaptive immune responses and promote health.”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579 · cited 1×
“The western dietary pattern, specifically reduced ingestion of plant-based fibers, may be a critical factor that links the gut microbiome to disease (23).”
BackgroundDiversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533 · cited 1×
“Gut microbiota-host immune misadaptation has been implicated in the rising incidence of IBD, other inflammatory diseases, and obesity (22).”
BackgroundInteractions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 1×
“Disruption of this homeostasis leads to intestinal inflammation and disease (2, 3).”
BackgroundInduction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752 · cited 4×
“The antibiotic vancomycin, which targets Gram-positive bacteria and disrupts the gut microbiota (12), reduces cTregs to similar levels as observed in GF mice (7) (fig.”
BackgroundInfluentialEcological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 1×
“Humans and mice rely on bacteria to breakdown undigestible dietary components, such as fibers (8).”
BackgroundRegulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241
Short chain fatty acids in human large intestine, portal, hepatic and venous blood
Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P., & Macfarlane, G. T. (1987) · Gut · doi:10.1136/gut.28.10.1221 · Cited by 3,119 · cited 2×
“In SPF mice, SCFA are taken up by colonic epithelial cells but also diffuse through the epithelium into the lamina propria where they can mediate their effects directly (9, 14).”
BackgroundBifidobacteria can protect from enteropathogenic infection through production of acetate
Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., Tobe, T., Clarke, J. M., Topping, D. L., Suzuki, T., et al. (2011) · Nature · doi:10.1038/nature09646 · Cited by 2,387 · cited 1×
“These results may explain the benefits of dietary fibers and bacteria, such as clostridia and bifidobacteria (13) that can increase colonic luminal SCFA production and modulate inflammation in mice and humans.”
Background
Cited by
Items 901–1,000 of 1,070
Ding, Y., Yanagi, K., Cheng, C., Alaniz, R. C., Lee, K., & Jayaraman, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.01.029 · Cited by 126
Microbiome and Autoimmune Uveitis
Horai, R., & Caspi, R. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00232 · Cited by 139
The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review
Wark, G., Samocha‐Bonet, D., Ghaly, S., & Danta, M. (2020) · Nutrients · doi:10.3390/nu13010135 · Cited by 151
Microbiome in cancer: Role in carcinogenesis and impact in therapeutic strategies
Rahman, M. M., Islam, M. R., Shohag, S., Ahasan, M. T., Sarkar, N., Khan, H., Hasan, A. M., Cavalu, S. D., & Rauf, A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112898 · Cited by 142
Microbial transmission in the social microbiome and host health and disease
Sarkar, A., McInroy, C. J. A., Harty, S., Raulo, A., Ibata, N. G. O., Valles‐Colomer, M., Johnson, K. V. ‐., Brito, I., Henrich, J., Archie, E. A., et al. (2024) · Cell · doi:10.1016/j.cell.2023.12.014 · Cited by 152
Regulatory T cells in the face of the intestinal microbiota
Ramanan, D., Pratama, A., Zhu, Y., Venezia, O., Sassone-Corsi, M., Chowdhary, K., Galván-Peña, S., Sefik, E., Brown, C., Gélineau, A., et al. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00890-w · Cited by 126
Kostovcikova, K., Coufal, S., Galanova, N., Fajstova, A., Hudcovic, T., Kostovcik, M., Prochazkova, P., Jiraskova Zakostelska, Z., Cermakova, M., Sediva, B., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00919 · Cited by 126
Canani, R. B., Filippis, F. D., Nocerino, R., Paparo, L., Scala, C. D., Cosenza, L., Gatta, G. D., Calignano, A., Caro, C. D., Laiola, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30428-3 · Cited by 142
The Human Microbiota and Asthma
Ver Heul, A., Planer, J., & Kau, A. L. (2019) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8719-7 · Cited by 125
Influence of maternal microbiota during pregnancy on infant immunity
Nyangahu, D. D., & Jaspan, H. B. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13331 · Cited by 151
Mucin O-glycans facilitate symbiosynthesis to maintain gut immune homeostasis
Yamada, T., Hino, S., Iijima, H., Genda, T., Aoki, R., Nagata, R., Han, K., Hirota, M., Kinashi, Y., Oguchi, H., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.008 · Cited by 143
T Cell Responses to the Microbiota
Ivanov, I. I., Tuganbaev, T., Skelly, A. N., & Honda, K. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101320-011829 · Cited by 124
Resistant starch and the gut microbiome: Exploring beneficial interactions and dietary impacts
Zhao, C. X., Liang, N., Zhang, H., Li, H., Guo, J., Zhang, Y., Chen, Y., Wang, Y., & Shi, N. (2024) · Food Chemistry X · doi:10.1016/j.fochx.2024.101118 · Cited by 194
Movahedi, M., Bishop, D. T., Macrae, F., Mecklin, J., Möslein, G., Olschwang, S., Eccles, D., Evans, D. G., Maher, E. R., Bertario, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.9952 · Cited by 130
Shimizu, J., Kubota, T., Takada, E., Takai, K., Fujiwara, N., Arimitsu, N. N., Ueda, Y., Wakisaka, S., Tomoko, S., & Suzuki, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153746 · Cited by 132
Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases
Dolan, K. T., & Chang, E. B. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600129 · Cited by 125
Immunity to Commensal Fungi: Detente and Disease
Wheeler, M. L., Limon, J. J., & Underhill, D. M. (2017) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100342 · Cited by 130
Gut dysbacteriosis and intestinal disease: mechanism and treatment
Meng, X., ZHANG, G., Cao, H., Yu, D., Fang, X., de Vos, W. M., & Wu, H. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14661 · Cited by 165
Balakrishnan, B., Luckey, D. H., Bodkhe, R., Chen, J., Marietta, E. V., Jeraldo, P., Murray, J. A., & Taneja, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.609644 · Cited by 131
Gut Microbiome and Metabolites in Systemic Lupus Erythematosus: Link, Mechanisms and Intervention
Zhang, L., Qing, P., Yang, H., Wu, Y., Liu, Y., & Luo, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.686501 · Cited by 155
Microbial short-chain fatty acids: a bridge between dietary fibers and poultry gut health — A review
Ali, Q., Ma, S., La, S., Guo, Z., Liu, B., Gao, Z., Farooq, U., Wang, Z., Zhu, X., Cui, Y., et al. (2022) · Animal Bioscience · doi:10.5713/ab.21.0562 · Cited by 151
Fatty acids and lipid mediators in inflammatory bowel disease: from mechanism to treatment
Yan, D., Ye, S., He, Y., Wang, S., Xiao, Y., Xiang, X., Deng, M., Luo, W., Chen, X., & Wang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1286667 · Cited by 146
Mining the human gut microbiota for effector strains that shape the immune system
Ahern, P. P., Faith, J. J., & Gordon, J. I. (2014) · Immunity · doi:10.1016/j.immuni.2014.05.012 · Cited by 123
Fatty acids as modulators of neutrophil recruitment, function and survival
Rodrigues, H. G., Takeo Sato, F., Curi, R., & Vinolo, M. A. R. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.098 · Cited by 124
“, 2009), T-cell-dependent colitis (Furusawa et al., 2013; Smith et al., 2013), thyoglicollate-induced peritonitis (Vinolo et al.”
BackgroundTHE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
Laterza, L., Rizzatti, G., Gaetani, E., Chiusolo, P., & Gasbarrini, A. (2016) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2016.025 · Cited by 124
Clavel, T., Gomes‐Neto, J. C., Lagkouvardos, I., & Ramer‐Tait, A. E. (2017) · Immunological Reviews · doi:10.1111/imr.12578 · Cited by 123
Development and Function of the Intestinal Microbiome and Potential Implications for Pig Production
Nowland, T. L., Plush, K. J., BARTON, M. D., & Kirkwood, R. N. (2019) · Animals · doi:10.3390/ani9030076 · Cited by 150
Yang, K., Hou, Y., Zhang, Y., Liang, H., Sharma, A., Zheng, W., Wang, L., Torres, R., Tatebe, K., Chmura, S. J., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201915 · Cited by 124
Sadrekarimi, H., Gardanova, Z. R., Bakhshesh, M., Ebrahimzadeh, F., Yaseri, A. F., Thangavelu, L. P., Hasanpoor, Z., Zadeh, F. A., & Kahrizi, M. S. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03492-7 · Cited by 143
Leaky Gut in IBD: Intestinal Barrier–Gut Microbiota Interaction
Yu, S., Sun, Y., Shao, X., Zhou, Y., Yu, Y., Kuai, X., & Zhou, C. (2022) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2203.03022 · Cited by 141
Vasquez, R., Oh, J. K., Song, J. H., & Kang, D. (2022) · Journal of Animal Science and Technology · doi:10.5187/jast.2022.e58 · Cited by 147
Effect of probiotics on depressive symptoms: a meta-analysis of human studies
Goh, K. K., Liu, Y.-W., Kuo, P.-H., Chung, Y.-C. E., Lu, M.-L., & Chen, C.-H. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112568 · Cited by 123
Gut microbiome and anticancer immune response: really hot Sh*t!
Viaud, S., Daillère, R., Boneca, I. G., Lepage, P., Langella, P., Chamaillard, M., Pittet, M. J., Ghiringhelli, F., Trinchieri, G., Goldszmid, R., et al. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.56 · Cited by 123
Food allergy: Insights into etiology, prevention, and treatment provided by murine models
Oyoshi, M. K., Oettgen, H. C., Chatila, T. A., Geha, R. S., & Bryce, P. J. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.12.1045 · Cited by 138
The role of gut microbiota in the pathogenesis of rheumatic diseases
Zhong, D., Wu, C., Zeng, X., & Wang, Q. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3821-4 · Cited by 139
Yan, J., & Charles, J. F. (2018) · Calcified Tissue International · doi:10.1007/s00223-018-0395-3 · Cited by 123
Turesky, R. J. (2018) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2018.718 · Cited by 144
Comprehensive characterization of toxicity of fermentative metabolites on microbial growth
Wilbanks, B. A., & Trinh, C. T. (2017) · Biotechnology for Biofuels · doi:10.1186/s13068-017-0952-4 · Cited by 130
The path toward using microbial metabolites as therapies
Descamps, H. C., Herrmann, B., Wiredu, D., & Thaiss, C. A. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.05.063 · Cited by 123
Dismicrobism in inflammatory bowel disease and colorectal cancer: Changes in response of colocytes
Tomasello, G., Tralongo, P., Damiani, P., Sinagra, E., Trapani, B. D., Zeenny, M. N., Hussein, I. H., Jurjus, A., & Leone, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i48.18121 · Cited by 138
Vikram, A., Kim, Y.-R., Kumar, S., Li, Q., Kassan, M., Jacobs, J. S., & Irani, K. (2016) · Nature Communications · doi:10.1038/ncomms12565 · Cited by 122
Wang, X., Cai, Z., Wang, Q., Wu, C., Sun, Y., Wang, Z., Xu, X., Xue, W., Cao, Z., Zhang, M., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.11.005 · Cited by 137
Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy
Drewes, J. L., Housseau, F., & Sears, C. L. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.189 · Cited by 121
Recent advances in modulation of cardiovascular diseases by the gut microbiota
Masenga, S. K., Hamooya, B., Hangoma, J., Hayumbu, V., Ertuglu, L. A., Ishimwe, J., Rahman, S., Saleem, M., Laffer, C. L., Elijovich, F., et al. (2022) · Journal of Human Hypertension · doi:10.1038/s41371-022-00698-6 · Cited by 121
Intestinal microbiota and its effects on the immune system: The immune system and the microbiota
Rescigno, M. (2014) · Cellular Microbiology · doi:10.1111/cmi.12301 · Cited by 121
Autoimmune host–microbiota interactions at barrier sites and beyond
Ruff, W. E., & Kriegel, M. A. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.02.006 · Cited by 121
Standardised animal models of host microbial mutualism
Macpherson, A. J., & McCoy, K. D. (2015) · Mucosal Immunology · doi:10.1038/mi.2014.113 · Cited by 121
Organ-Specific and Memory Treg Cells: Specificity, Development, Function, and Maintenance
Gratz, I. K., & Campbell, D. J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00333 · Cited by 121
Nakajima, A., Kaga, N., Nakanishi, Y., Ohno, H., Miyamoto, J., Kimura, I., Hori, S., Sasaki, T., Hiramatsu, K., Okumura, K., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700248 · Cited by 121
Cheng, M., Zhang, X., Zhu, J., Cheng, L., Cao, J., Wu, Z., Weng, P., & Zheng, X. (2018) · Food & Function · doi:10.1039/c7fo01570d · Cited by 121
Juanola, O., Ferrusquía-Acosta, J., García-Villalba, R., Zapater, P., Magaz, M., Marín, A., Olivas, P., Baiges, A., Bellot, P., Turon, F., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901327r · Cited by 120
Dysbiosis: from fiction to function
Tiffany, C. R., & Bäumler, A. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00230.2019 · Cited by 148
Ribeiro, C. F. A., Silveira, G. G. D. O. S., Cândido, E. D. S., Cardoso, M. H. E. S., Carvalho, C. M. E., & Franco, O. L. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00036 · Cited by 139
Zhou, Y., Wang, Y., Quan, M., Zhao, H., & Jia, J. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201497 · Cited by 136
The maternal gut microbiome during pregnancy and offspring allergy and asthma
Gao, Y., Nanan, R. K. H., Macia, L., Tan, J., Sominsky, L., Quinn, T. P., O’Hely, M., Ponsonby, A., Tang, M. L. K., Collier, F., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.07.011 · Cited by 141
Kim, B., Wang, Y.-C., Hespen, C. W., Espinosa, J., Salje, J., Rangan, K. J., Oren, D. A., Kang, J. Y., Pedicord, V. A., & Hang, H. C. (2019) · eLife · doi:10.7554/elife.45343 · Cited by 120
Deciphering the tête-à-tête between the microbiota and the immune system
Surana, N. K., & Kasper, D. L. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72332 · Cited by 120
Epigenetic modifications of the immune system in health and disease
Obata, Y., Furusawa, Y., & Hase, K. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2014.114 · Cited by 135
Chakraborty, K., Raundhal, M., Chen, B. B., Morse, C., Tyurina, Y. Y., Khare, A., Oriss, T. B., Huff, R., Lee, J. S., St. Croix, C. M., et al. (2017) · Nature Communications · doi:10.1038/ncomms13944 · Cited by 120
Antigen-specific regulatory T-cell responses to intestinal microbiota
Russler-Germain, E. V., Rengarajan, S., & Hsieh, C.-S. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.65 · Cited by 131
Recent developments and highlights in mechanisms of allergic diseases: Microbiome
Lunjani, N., Satitsuksanoa, P., Lukasik, Z., Sokolowska, M., Eiwegger, T., & O'Mahony, L. (2018) · Allergy · doi:10.1111/all.13634 · Cited by 120
Holota, Y., Dovbynchuk, T., Kaji, I., Vareniuk, І., Dzyubenko, N., Chervinska, T., Zakordonets, L. V., Стецька, В. О., Остапченко, Л. І., Serhiichuk, T., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220642 · Cited by 136
The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
König, R. S., Albrich, W. C., Kahlert, C. R., Bahr, L. S., Löber, U., Vernazza, P., Scheibenbogen, C., & Forslund, S. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.628741 · Cited by 149
Gut microbiome-mediated regulation of neuroinflammation
Bostick, J. W., Schonhoff, A. M., & Mazmanian, S. K. (2022) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102177 · Cited by 126
Predicting butyrate- and propionate-forming bacteria of gut microbiota from sequencing data
Kircher, B., Woltemate, S., Gutzki, F. M., Schlüter, D., Geffers, R., Bähre, H., & Vital, M. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2149019 · Cited by 139
The composition of the microbiota modulates allograft rejection
Lei, Y. M., Chen, L., Wang, Y., Stefka, A. T., Molinero, L. L., Theriault, B. R., Aquino-Michaels, K., Sivan, A., Nagler‐Anderson, C., Gajewski, T. F., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85295 · Cited by 124
Tao, J., Li, S., Gan, R.-Y., Zhao, C.-N., Meng, X., & Li, H.-B. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1555789 · Cited by 119
Bai, Y., Li, Y., Marion, T. N., Tong, Y., Zaiss, M. M., Tang, Z., Zhang, Q., Liu, Y., & Luo, Y. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102564 · Cited by 131
Campbell, C., Dikiy, S., Bhattarai, S. K., Chinen, T., Matheis, F., Calafiore, M., Hoyos, B., Hanash, A., Mucida, D., Bucci, V., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.013 · Cited by 117
Turroni, S., Magnani, M., KC, P., Lesnik, P., Vidal, H., & Heer, M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.553929 · Cited by 117
Gut microbiota and old age: Modulating factors and interventions for healthy longevity
Coman, V., & Vodnar, D. C. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111095 · Cited by 118
Gut Microbiota in Intestinal and Liver Disease
Jones, R. M., & Neish, A. S. (2020) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-030320-095722 · Cited by 123
Magliocca, G., Mone, P., Iorio, B. R. D., Heidland, A., & Marzocco, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105354 · Cited by 138
Diet, microbiota, and the mucus layer: The guardians of our health
Suriano, F., Nyström, E. E. L., Sergi, D., & Gustafsson, J. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.953196 · Cited by 136
Short chain fatty acids, a possible treatment option for autoimmune diseases
Golpour, F., Abbasi-Alaei, M., Babaei, F., Mirzababaei, M., Parvardeh, S., Mohammadi, G., & Nassiri‐Asl, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114763 · Cited by 133
Relationship between gut microbiota and development of T cell associated disease
Kosiewicz, M. M., Dryden, G. W., Chhabra, A., & Alard, P. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.03.019 · Cited by 117
In vitro fermentation of alginate and its derivatives by human gut microbiota
Li, M., Li, G., Shang, Q., Chen, X., Liu, W., Pi, X., Zhu, L., Yin, Y., Yu, G., & Wang, X. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.02.003 · Cited by 128
Hoggard, M., Wagner Mackenzie, B., Jain, R., Taylor, M. W., Biswas, K., & Douglas, R. G. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00060-16 · Cited by 117
Regulatory T cells in the tumour microenvironment
Imianowski, C. J., Chen, Q., Workman, C. J., & Vignali, D. A. A. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00832-9 · Cited by 159
Impact of early gut microbiota on immune and metabolic development and function
Wang, M., Monaco, M. H., & Donovan, S. M. (2016) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2016.04.004 · Cited by 140
Role of Metabolism in the Immunobiology of Regulatory T Cells
Galgani, M., De Rosa, V., La Cava, A., & Matarese, G. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600242 · Cited by 116
The Influence of the Microbiome on Allergic Sensitization to Food
Plunkett, C. H., & Nagler, C. R. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601266 · Cited by 117
Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis
Pereira, L. M. S., Gomes, S. T. M., Ishak, R., & Vallinoto, A. C. R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00605 · Cited by 138
Jiminez, J. A., Uwiera, T. C., Abbott, D. W., Uwiera, R. R. E., & Inglis, G. D. (2017) · mSphere · doi:10.1128/msphere.00243-17 · Cited by 136
Sánchez‐Alcoholado, L., Castellano‐Castillo, D., Jordán-Martínez, L., Moreno‐Indias, I., Cardila-Cruz, P., Elena-Aldana, D. J., Muñoz-García, A. J., Queipo‐Ortuño, M. I., & Jiménez-Navarro, M. F. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01936 · Cited by 118
Laserna-Mendieta, E. J., Clooney, A. G., Carretero-Gomez, J. F., Moran, C., Sheehan, D., Nolan, J. A., Hill, C., Gahan, C. G. M., Joyce, S. A., Shanahan, F., et al. (2018) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx137 · Cited by 116
Moffett, J. R., Puthillathu, N., Vengilote, R., Jaworski, D. M., & Namboodiri, A. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.580171 · Cited by 115
Gut microbiota and bone metabolism
Lu, L., Chen, X., Liu, Y., & Yu, X. (2021) · The FASEB Journal · doi:10.1096/fj.202100451r · Cited by 115
Foley, S. E., Tuohy, C. A., Dunford, M., Grey, M. J., Luca, H. E. D., Cawley, C., Szabady, R. L., Maldonado‐Contreras, A., Houghton, J. M., Ward, D. V., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01137-3 · Cited by 130
Molecular and Cellular Mechanisms Influenced by Postbiotics
Jastrząb, R., Graczyk, D., & Siedlecki, P. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413475 · Cited by 141
Skin immunity: dissecting the complex biology of our body's outer barrier
Zhang, C., Merana, G. R., Harris-Tryon, T. A., & Scharschmidt, T. C. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00505-y · Cited by 141
Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome
Deng, H., Chen, Y., Xing, J., Zhang, N., & Xu, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1470283 · Cited by 170
Fostering of advanced mutualism with gut microbiota by Immunoglobulin A
Sutherland, D. B., Suzuki, K., & Fagarasan, S. (2016) · Immunological Reviews · doi:10.1111/imr.12384 · Cited by 115
Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy
Shui, L., Yang, X., Li, J., Yi, C., Sun, Q., & Zhu, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02989 · Cited by 115
“In contrast, patients with more NR microorganisms often had a shortened PFS and a higher level of Tregs with a blunted cytokine response.”
BackgroundInfluentialZhao, L., Xiong, Q., Stary, C. M., Mahgoub, O. K., Ye, Y., Gu, L., Xiong, X., & Zhu, S. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1382-3 · Cited by 113
Ikeda-Ohtsubo, W., Brugman, S., Warden, C. H., Rebel, J. M. J., Folkerts, G., & Pieterse, C. M. J. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00090 · Cited by 115
Commensal microbiota regulates T cell fate decision in the gut
Furusawa, Y., Obata, Y., & Hase, K. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0455-3 · Cited by 131
Risk Factor Profiles Differ for Cancers of Different Regions of the Colorectum
Wang, L., Lo, C., He, X., Hang, D., Wang, M., Wu, K., Chan, A. T., Ogino, S., Giovannucci, E. L., & Song, M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.054 · Cited by 122
Kibbie, J. J., Dillon, S. M., Thompson, T. A., Purba, C. M., McCarter, M. D., & Wilson, C. C. (2021) · Immunobiology · doi:10.1016/j.imbio.2021.152126 · Cited by 109
Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease
Hayase, E., Hayase, T., Jamal, M. A., Miyama, T., Chang, C., Ortega, M. R., Ahmed, S., Karmouch, J. L., Sanchez, C. A., Brown, A. N., et al. (2022) · Cell · doi:10.1016/j.cell.2022.09.007 · Cited by 122
Metadata
- Authors
- Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S.
- Affiliations
- Harvard University (US)
- AstraZeneca, RAD-Transgenic, Mölndal, Sweden.
- Broad Institute (US)
- Corresponding author
- Garrett, Wendy S.
- Venue
- Science
- Published
- 2013-08-02
- Volume
- 341
- Issue
- 6145
- Pages
- 569-573
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3807819
- OpenAlex
- W2060185417
- Cited by
- 5,413
- References
- 28
- Citations by year
- 2026: 483 · 2025: 507 · 2024: 556 · 2023: 551 · 2022: 497 · 2021: 560 · 2020: 452 · 2019: 403 · 2018: 344 · 2017: 319 · 2016: 276 · 2015: 226 · 2014: 204 · 2013: 31
- FWCI
- 109.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Cancer Institute (R01CA154426)
- National Institute of General Medical Sciences (R01GM099537)
- National Institute of Allergy and Infectious Diseases (K08AI078942)
- National Institute of Diabetes and Digestive and Kidney Diseases (F32DK098826, F32DK095506, P30DK034854)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- regulatory T cells, Foxp3, short-chain fatty acids, gut microbiota, microbial metabolites, colitis, FFAR2, intestinal inflammation, bacterial fermentation products
- MeSH terms
- Animals, Bacteria, Colitis, Colon, DNA-Binding Proteins, Fatty Acids, Volatile, Fermentation, Germ-Free Life, Homeostasis, Humans, Mice, Inbred BALB C, Mice, Inbred C57BL, Receptors, G-Protein-Coupled, T-Lymphocytes, Regulatory, Mice, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.